How to Buy Retatrutide in Dubai
A researcher’s guide to sourcing verified retatrutide in the UAE — purity standards, supplier evaluation, format selection, and regulatory context.
Update History ▾
Retatrutide (LY3437943) is the first triple-agonist peptide compound, currently in Phase 3 trials under Eli Lilly’s TRIUMPH programme. In the UAE, it is available for in-vitro research through verified suppliers. Key evaluation criteria: third-party purity testing (minimum 99% HPLC), Janoshik or equivalent COA, prefilled pen format for dosing precision, and cold-chain delivery. Remy Peptides supplies 30mg prefilled FlexiPens verified at 99.262% purity with same-day Dubai delivery and a complimentary 20mg pen included with every order.
Janoshik-verified, HPLC ≥99.2% purity. Retatrutide Pen 30 mg from AED 1,500/pen. Ships from Dubai.
What Is Retatrutide?
Retatrutide (LY3437943) is a triple-agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor). This three-receptor mechanism distinguishes it from single-agonist compounds like semaglutide and dual-agonist compounds like tirzepatide.
In a Phase 2 trial published in the New England Journal of Medicine, retatrutide demonstrated a 24.2% mean body weight reduction at the highest dose over 48 weeks. Eli Lilly’s Phase 3 TRIUMPH clinical trial programme is currently enrolling participants globally, with FDA submission anticipated in late 2026 or 2027. For a detailed regulatory timeline, see our retatrutide approval status tracker.
All retatrutide materials supplied by Remy Peptides are strictly for in-vitro laboratory research and are not intended for human or veterinary administration.
UAE Regulatory Landscape for Research Peptides
Understanding the regulatory framework is essential before sourcing any research compound in the UAE. Retatrutide occupies a specific position within this framework that researchers should be aware of.
Under MoHAP Circular 17/2022, research-grade peptides that are clearly labelled for in-vitro laboratory use and are not marketed for human consumption operate within the existing regulatory framework. Retatrutide is not classified as a controlled substance in any UAE jurisdiction. As an investigational compound without regulatory approval from the FDA or any other authority, it falls outside the scope of scheduled pharmaceutical regulations.
This is distinct from approved prescription GLP-1 medications like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro), which are regulated pharmaceuticals available only through licensed pharmacies with a prescription. Retatrutide will not be available through clinical channels until after FDA approval and subsequent MoHAP regulatory review.
The requirement is that all materials carry “For Research Use Only” labelling and that no therapeutic claims are made. For a broader overview of peptide legality across jurisdictions, see our peptide legality guide and our peptides in the UAE overview.
What to Look for in a Retatrutide Supplier
Not all peptide suppliers maintain equivalent quality standards. The following criteria separate verified research-grade sources from unreliable ones. Applying this checklist before placing any order protects both research integrity and laboratory budgets.
Third-Party Purity Testing
The single most important indicator of a legitimate supplier is independent purity verification. Demand HPLC (High-Performance Liquid Chromatography) analysis conducted by a third-party laboratory — not an in-house test. A minimum threshold of 99% purity is standard for research-grade retatrutide. Remy Peptides uses Janoshik Analytical, an independent Czech laboratory widely recognised in the peptide research community, and publishes full test results for every batch.
Certificate of Analysis
A genuine COA is batch-specific, dated, and includes quantitative HPLC data with retention times and peak area percentages. Generic specification sheets or undated documents are insufficient. Every Remy Peptides batch COA is published at /coa/ with the batch number, test date, and complete analytical results. Batch RETP002 is verified at 99.262% purity.
Format and Delivery
Retatrutide is available in three formats: prefilled pen, lyophilised powder vial, and raw powder. For laboratory research requiring precise dosing, prefilled pens eliminate reconstitution errors and contamination risk. In Dubai’s climate — where summer temperatures regularly exceed 45°C — cold-chain delivery is not optional. Insulated, temperature-monitored packaging is essential to preserve peptide integrity from dispatch to laboratory receipt. For a complete breakdown of pen mechanics and dosing protocols, see our retatrutide pen guide.
Pricing Transparency
Reputable suppliers publish pricing in local currency (AED) without hidden fees for shipping, cold-chain packaging, or COA documentation. Volume discounts should be clearly tiered. Any supplier that cannot provide upfront pricing or requires negotiation before revealing costs warrants caution.
Prefilled Pen vs Vial: Which Format for Dubai Research?
Format selection directly impacts dosing accuracy, contamination risk, and workflow efficiency in the laboratory. The following comparison covers the key variables researchers should evaluate.
| Criterion | Prefilled Pen | Lyophilised Vial |
|---|---|---|
| Format | Ready-to-use FlexiPen | Powder requiring reconstitution |
| Dosing Precision | 0.1mg per click (mechanical) | Volumetric (syringe-dependent) |
| Contamination Risk | Minimal (sealed system) | Higher (reconstitution step) |
| Storage Stability | High (factory-sealed) | Moderate (post-reconstitution) |
| Preparation Time | None | 5–10 minutes per vial |
| Cost per mg (30mg) | AED 60/mg (single) — AED 50/mg (5-pack) | Varies widely by source |
For most Dubai-based research protocols, the prefilled pen format offers superior dosing reproducibility and eliminates the primary contamination vector associated with powder reconstitution. The sealed pen system also provides better thermal stability during last-mile delivery — a significant consideration in the UAE climate.
For detailed guidance on pen mechanics and click-based titration, see our retatrutide pen guide. For storage protocols across all formats, see our peptide stability and storage guide.
Retatrutide Pricing in Dubai
Remy Peptides publishes transparent AED pricing across three volume tiers for the 30mg prefilled FlexiPen:
- 1 pen: AED 1,800
- 3-pack: AED 1,650/pen (AED 4,950 total)
- 5-pack: AED 1,500/pen (AED 7,500 total)
Every 30mg pen order includes a complimentary 20mg research pen — bringing a single-pen order to 50mg for AED 1,800 (effective rate of AED 36/mg). This is the lowest verified cost per milligram for HPLC-tested retatrutide in the UAE market.
Red flag: Prices significantly below AED 1,400 per 30mg pen should trigger due diligence. Sub-market pricing typically indicates compromised purity, lack of third-party testing, or substituted compounds. Always request a batch-specific COA before purchasing from any supplier.
View current pricing and availability at our Dubai pricing page or proceed directly to /order.
How to Order Retatrutide in Dubai
The ordering process at Remy Peptides is designed for speed and verification. Four steps from selection to delivery:
- Select quantity: Choose your pen quantity and format at /order. Volume tiers are applied automatically.
- Choose payment method: Bank transfer (UAE local or international SWIFT) or USDT (TRC-20 network). Payment details are provided at checkout.
- Confirm via WhatsApp: Send payment confirmation to +34 672 737 521. Our team verifies and prepares your order for dispatch.
- Same-day delivery: Orders placed before 4 PM receive same-day delivery within Dubai. Abu Dhabi, Sharjah, and other emirates receive next-day delivery (order by 12 PM). All shipments use temperature-controlled packaging.
Every order includes a Janoshik-verified Certificate of Analysis, cold-chain delivery, and WhatsApp support for tracking. For institutional or bulk procurement beyond the standard 5-pack tier, contact us via Telegram at @propeptide or see our wholesale page.
99.262% HPLC purity, Janoshik Analytical. Complimentary 20mg pen with every order. Cold-chain shipping.
How We Evaluated This Guide
This guide draws on clinical data from Eli Lilly’s TRIUMPH trial programme, published Phase 2 results in the New England Journal of Medicine, Janoshik Analytical test reports for Remy Peptides batch RETP002, and UAE regulatory documents including MoHAP Circular 17/2022. All supplier evaluation criteria are based on analytical chemistry standards and peptide stability research. Read our editorial policy →
- Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514-526.
- Eli Lilly and Company. TRIUMPH Clinical Trial Program for Retatrutide (LY3437943). ClinicalTrials.gov.
- Janoshik Analytical — Certificate of Analysis, Batch RETP002. HPLC purity: 99.262%. View COA.
- UAE Ministry of Health and Prevention. Circular 17/2022: Regulatory Framework for Research Materials.
- Coskun T, et al. LY3437943, a novel triple GIP/GLP-1/glucagon receptor agonist for glycaemic control and weight loss. Lancet. 2022;400(10366):1869-1881.
Retatrutide Pen 30 mg
99.262% HPLC purity, Janoshik Analytical. 300 clicks per pen, ships from Dubai. Complimentary 20mg pen included.
Order Retatrutide Pen →